Danaher Corp. (DHR) hisse senedi — iyi bir şirket mi?

Danaher Corp. (DHR) hisse senedi — iyi bir şirket mi? — InspectStocks

Nasıl para kazanıyor

Biotechnology: equipment, supplies, and services for biological drug research and manufacturing%30
Life Sciences: research instruments, supplies, and filtration products%30
Diagnostics: instruments, tests, and patient-monitoring products%40

Gelir payları six months ended June 26, 2026 dönemi için tahmindir; resmî bir bildirimden alınmış rakamlar değildir.

Rekabet ettiği şirketler

Ne satıyor6

Cytiva bioprocessing products
Filters, resins, liquids, single-use equipment, and services that drugmakers use to develop and manufacture biological medicines.
Pall filtration products
Filters and related equipment that remove contaminants from liquids and gases used in medicine, research, food production, electronics manufacturing, and other industries.
Biacore 8S
A Cytiva instrument that lets researchers test how potential drug molecules interact with their targets.

3 tane daha göster

SCIEX mass spectrometers
Instruments that identify and measure molecules in samples, used in drug research, clinical testing, and food and environmental testing.
Beckman Coulter clinical testing systems
Laboratory instruments, tests, and software that analyze blood and other body samples to help diagnose and monitor health conditions.
Cepheid GeneXpert tests
Systems and tests that detect genetic material from organisms or diseases, including tests used in hospitals and other care settings.

Kim alıyor5

Pharmaceutical and biotechnology companies buy research tools, drug-manufacturing equipment, and replacement supplies, often through Danaher's direct sales teams or distributors.
Contract manufacturers and contract development organizations buy equipment, supplies, and services to make medicines for other companies.
Universities, research institutes, and academic laboratories buy instruments and consumables for biological research.

2 tane daha göster

Hospitals, doctors' offices, and reference laboratories buy diagnostic instruments, tests, and patient-monitoring products.
Industrial customers, including semiconductor, food, energy, and aerospace businesses, buy filtration equipment and replacement filters.

Neye dayanıyor ve onu ne yıkabilir

Faaliyetin dayandığı şeyler

1Some specially specified or regulated components can be obtained from only one supplier or a limited number of suppliers, even though Danaher says no single supplier is material to the company as a whole.
2Danaher sells mainly through its own sales teams and also uses independent distributors; changes in distributor performance or customer purchasing patterns can affect sales.
3Sales depend in part on regulatory clearances and approvals, and on healthcare providers' ability to obtain payment or reimbursement for products and services.

Ters gidebilecekler

1Competitors and new technologies can take demand or lead to price reductions in Danaher's many product markets.
2Regulatory requirements for medical devices and diagnostic tests, along with changes in healthcare reimbursement and cost controls, can delay sales or affect what customers buy and pay.
3A few large commercial drug manufacturers delayed planned shipments of chromatography resins in the second quarter of 2026, illustrating how customer production schedules and facility readiness can shift biotechnology sales.

Tüm finansal tablolar →

Danaher Corp. hakkında

Danaher owns more than 15 operating companies grouped into biotechnology, life sciences, and diagnostics. Their products help researchers study cells and other biological material, help drugmakers make biological medicines, and help healthcare workers test samples and monitor patients. Many products are used up or replaced regularly, so customers buy supplies as well as instruments and services.

Merkez: Washington, D.C., United States
Kuruluş: 1984
Çalışan sayısı: Approximately 60,000 (as of December 31, 2025, high)
İşlem gördüğü borsa: NYSE
Mali yıl sonu: December 31

Danaher Corp. şirketinin ABD Menkul Kıymetler ve Borsa Komisyonu’na (SEC) sunduğu kendi belgelerinden kuruldu. Rakamlar bildirildiği gibidir; hisse başına geçmiş bugünkü hisse tabanına göre yeniden hesaplanmıştır. Bu bir işletmeyi anlatır — yatırım tavsiyesi değildir ve alma ya da satma önerisi değildir.

Keep exploring

The themes Danaher is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

The theme it is part of

Highest-graded in Diagnostics and Research

Graded A or B and worth $2B or more: A first, then the largest.

All 42 graded companies in its industry

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

All grade rises